The opioid epidemic is the number-one killer of Americans under the age of 50, and though medication-assisted treatments (MAT) are a proven, effective treatment option, limited access to care remains a barrier in many areas of the country. Ophelia is changing that by reinventing addiction treatment and dramatically improving access to best-in-class MAT with the reach and convenience of telemedicine. Menlo Ventures invested in their Series A in 2021.
Greg is a partner at Menlo Ventures, where he invests in teams trying to solve major problems in life science and healthcare, with a special interest in novel therapeutic platforms, digital health, and transformative technologies. Since joining in 2017, Greg has led Menlo investments including Cartwheel, Clear Labs, Curie, Delfi,…
